75 males between the age of 25-50 years, selected based on specific criteria outlined in the study. The duration of the study was 84 days, with frequent visits, exams and questionnaires to track changes. Each subject was given the daily recommended dosage for the duration of the test.
The “International Index of Erectile Function”, initially created to measure the results of prescription medications were used to measure results of VigRX Plus. This was a randomized double-blind study, in which half the subjects were given VigRX Plus and the other half was given a placebo.
All increases and improvements were measured directly against results from the placebo group.
What is the “International Index of Erection Function” (IIEF)?
(Study Conducted By Research Organization: Vedic Lifesciences Pvt.)
The VigRX Plus clinical study was designed to evaluate the effectiveness and safety of VigRX Plus in erectile dysfunction and male sexual health.
The test parameters and methodology included:
The 75 men who participated in the study were between the ages of 25 and 50, in monogamous, heterosexual relationships.
They agreed to take the recommended dose of VigRX Plus®, which is two tablets, twice per day with meals for 12 weeks.
Out of 108 applicants screened, 78 were recruited for participation in the trial, and 75 completed the trial.
No participants had major psychiatric disorders, a history of heart conditions, diabetes, spinal cord injuries, deformities of the penis, HIV/Aids, or sexually transmitted diseases. None were alcoholics, used medications known to cause sexual dysfunction, had liver or renal dysfunction, erection issues caused by low testosterone, or had female partners who were pregnant.
The inability to maintain an erection is a serious problem, affecting men of all ages.After taking VigRX Plus for 84 days, subjects saw a 62.82%improvement in their ability to maintain and control their erection when compared to the group taking placebo as demonstrated in the below chart.
Another important finding in this study was that the treatment satisfaction of the patients was also corroborated by their partners. In other words not only were the patients extremely satisfied with the results achieved when taking VigRX Plus, their partners also reported the same level of satisfaction.
More specifically the female partners of the patients reported and 59.97% increase in penetration, dramatically increasing overall satisfaction. And while partner satisfaction of the
VigRX Plus group actually increased during the study, the placebo group actually decreased over the same period! The chart below clearly demonstrates this substantial increase.
Over the test period there was a 22.49% improvement in orgasmic function which simply means the patients taking VigRX reported achieving 22.49% more orgasms than patients taking placebo.And more orgasms definitely equates to greater overall sexual satisfaction.
This is a very important statistic, further demonstrating why VigRX Plus could be considered superior to prescription medication.You see, prescription medication primarily focuses on increasing erection quality but does not impact sexual desire. This means that patients taking prescription medication can achieve an erection but do not necessarily desire OR find the act of performing intercourse satisfying.Whereas VigRX Plus focuses on both improving erection quality and sexual desire which means overall sexual and intercourse satisfaction increased dramatically!
The patients taking VigRX plus for 84 days reported a 71.43% improvement in sexual and intercourse satisfaction where the placebo group only reported 12%.This means patients taking VigRX Plus found greater satisfaction – almost 6 times higher than the placebo group – when performing intercourse!.
And finally when all of the results were in, after 84 days the patients taking VigRX Plus reported a 61.00% increase in their overall sexual satisfaction.To further validate the findings the placebo group actually reported a decrease in overall sexual satisfaction!
Important Fact: Remember this was a “Double Blind Study” which means both the doctors and the researchers recording the data had no idea whether they were receiving placebo or genuine VigRX Plus in order to completely eliminate ANY bias in the results.